Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Morning Overview on MSN
CRISPR revives ancient gene to block gout and fatty liver
Reviving an ancient human gene that prevents gout and fatty liver disease, scientists at Georgia State University have marked ...
Researchers have discovered a handful of new CRISPR-Cas systems that could add to the capabilities of the already transformational gene editing and DNA manipulation toolbox. Of the new recruits, one ...
Update: On 8 December, the US Food and Drug Administration approved the CRISPR–Cas 9 therapy for sickle cell disease described in this story. Less than a month after the world’s first approval of a ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
The University of Chicago Medicine Comer Children’s Hospital is one of only nine centers nationwide authorized to use the newly approved CRISPR-based treatment for sickle cell disease in patients 12 ...
Nobel Prize winner and CRISPR DNA-editing pioneer Jennifer A. Doudna, PhD, spoke Thursday at Fred Hutch Cancer Center in Seattle. Her lecture kicked off the President’s Seminar series, presented by ...
Young adult mice with a genetic form of progressive deafness can hear again after being treated with an experimental CRISPR gene therapy that its creators hope to eventually use in humans. In an ...
Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...
A detailed look at the predicted structure of a new CRISPR-Cas tool that promises to expand the genomic editing and manipulating abilities of the original. Researchers at Duke University and North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback